ArticleGene therapy2016
CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting.
D G Courtney et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
72 papers cite itlatest 60 shown
this papercites it